ACM
TMO icon

Ativo Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Ativo Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,631
Closed -$1.75M – 128
2021
Q4 		$1.75M Sell
2,631
-67
-2% -$41.8K 0.78% 45
2021
Q3 		$1.54M Sell
2,698
-2,686
-50% -$1.47M 0.72% 48
2021
Q2 		$2.72M Buy
5,384
+348
+7% +$164K 1.15% 13
2021
Q1 		$2.3M Sell
5,036
-635
-11% -$303K 0.97% 18
2020
Q4 		$2.64M Sell
5,671
-2
-0% -$938 1.14% 14
2020
Q3 		$2.5M Buy
5,673
+551
+11% +$228K 1.2% 13
2020
Q2 		$1.86M Sell
5,122
-15
-0.3% -$5.03K 1% 24
2020
Q1 		$1.46M Sell
5,137
-1,141
-18% -$360K 0.91% 28
2019
Q4 		$2.04M Sell
6,278
-51
-0.8% -$15.5K 0.94% 16
2019
Q3 		$1.84M Sell
6,329
-1,500
-19% -$430K 0.9% 19
2019
Q2 		$2.3M Sell
7,829
-2,829
-27% -$779K 1.04% 15
2019
Q1 		$2.92M Sell
10,658
-100
-0.9% -$24.9K 1.23% 8
2018
Q4 		$2.41M Sell
10,758
-1,727
-14% -$405K 1.13% 12
2018
Q3 		$3.05M Sell
12,485
-104
-0.8% -$23.9K 0.81% 13
2018
Q2 		$2.61M Sell
12,589
-375
-3% -$79.6K 0.73% 24
2018
Q1 		$2.68M Buy
12,964
+50
+0.4% +$10.5K 0.76% 19
2017
Q4 		$2.45M Buy
12,914
+4,524
+54% +$867K 0.65% 27
2017
Q3 		$1.59M Hold
8,390
– – 0.43% 71
2017
Q2 		$1.46M Buy
+8,390
New +$1.41M 0.4% 82
2016
Q4 		– Sell
-20,725
Closed -$3.3M – 232
2016
Q3 		$3.3M Buy
20,725
+10,700
+107% +$1.65M 0.76% 33
2016
Q2 		$1.48M Buy
+10,025
New +$1.48M 0.36% 86

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ativo Capital Management's TMO Position: Q1 2022 in Review

Ativo Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 2,631 shares — an estimated $1.75M sold.

Ativo Capital Management first reported a position in TMO in Q2 2016 and held it in 21 quarters. The position peaked at $3.3M in Q3 2016. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Ativo Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
  • Ativo Capital Management sold 2,631 Thermo Fisher Scientific shares in Q1 2022, an estimated $1.75M.
  • Ativo Capital Management first reported a position in Thermo Fisher Scientific in Q2 2016 and held it in 21 quarters.
  • Ativo Capital Management's Thermo Fisher Scientific position peaked at $3.3M in Q3 2016.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Ativo Capital Management's 13F filing for Q1 2022, filed 13 May 2022.